Apheresis and the thrombotic thrombocytopenic purpura syndrome: Current advances in diagnosis, pathophysiology, and management

Therapeutic Apheresis

Volumn 3, Issue 1, 1999, Pages 20-24

  Brailey, Lisa Louise ^a   Brecher, Mark E ^a   Bandarenko, Nicholas ^a  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

Apheresis; Lactate dehydrogenase; Metalloproteinase; Microangiopathic hemolytic anemia; Occult infection; Plasma; Platelets; Therapeutic plasma exchange; Thrombocytopenia; Thrombotic thrombocytopenic purpura

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CYCLOPHOSPHAMIDE; DIPYRIDAMOLE; PREDNISONE; STEROID; SULFINPYRAZONE; TICLOPIDINE; VINCRISTINE;

APHERESIS; ARTICLE; HUMAN; PATHOPHYSIOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; SPLENECTOMY; SURVIVAL RATE; SYNDROME DELINEATION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

BLOOD COMPONENT REMOVAL; HUMANS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RECURRENCE;

EID: 0033004803     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.1999.00143.x     Document Type: Article

References (37)

1. Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: A hitherto underscribed disease. Proc NY Pathol Soc 1924;24:21-4.
2. Bandarenko N, Brecher ME, Members of the United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group. United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): Multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange. J Clin Apheresis 1998;13:133-41.
3. Torok TJ, Holman RC, Chorba TL. Increasing mortality from thrombotic thrombocytopenic purpura in the United States - analysis of national mortality data, 1968-1991. Am J Hematol 1995;50(2):84-90.
4. Moake JL. Haemolytic-uraemic syndrome: Basic science. Lancet 1994;343:393-401.
5. Bell W. Thrombotic thrombocytopenic purpura. JAMA 1991; 265:91-3.
6. Bukowski RM. Thrombotic thrombocytopenic purpura: A review. Prog Hemost Thromb 1982;6:287-337.
7. Cohen JA, Brecher ME, Bandarenko N. Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura. J Clin Apheresis 1998; 13:16-9.
8. Caggiano V, Fernando LP, Schneider JM, Haesslein HC, Watson-Williams EJ. Thrombotic thrombocytopenic purpura: Report of fourteen cases - occurrence during pregnancy and response to plasma exchange. J Clin Apheresis 1983;1(2): 71-85.
9. Kwaan HC. Miscellaneous secondary thrombotic microangiopathy. Semin Hematol 1987;24:141-7.
10. Wysowski DK, Green L. Serious adverse events in Norplant users reported to the Food and Drug Administration's Med-Watch Spontaneous Reporting System. Obstet Gynecol 1995;86(2):318-20.
11. Chart H, Smith HR, Scotland SM, Rowe B, Milford DV, Taylor CM. Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet 1991;337: 138-40.
12. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone marrow transplant 1994; 14:495-504.
13. Murgo JM. Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents. Semin Hematol 1987;24(3):161-77.
14. Snyder HW, Mittelman A, Oral A, Messerschmidt GL, Henry DH, Korec S, Bertram JH, Guthrie TH, Ciavarella D, Wuest D, Perkins W, Balint JP, Cochran SK, Peugeot RL, Jones FR. Treatment of cancer chemotherapy associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by Protein A immunoadsorption of plasma. Cancer 1993;71: 1882-92.
15. Ucar A, Fernandez HF, Byrnes JJ, Lian EC-Y, Harrington WJ. Thrombotic microangiopathy and retroviral infections: A 13-year experience. Am J Hematol 1994;45:304-9.
16. Page Y, Tardy B, Zeni F, Comtet C, Terrana R, Bertrand JC. Thrombotic thrombocytopenic purpura related to ticlopidine. Lancet 1991;337:774-6.
17. Bennett CL, Weinberg PD, Rozenberg-Ben-Dror K, Yarnold PR, Kwaan HC, Green D. Thrombotic thrombocytopenia purpura associated with ticlopidine: A review of 60 cases. Ann Intern Med 1998;128:541-4.
18. Bennett CL, Kiss JE, Weinberg PD, Pinevich AJ, Green D, Kwaan HC, Feldman MD. Thrombotic thrombocytopenic purpura after stenting and ticlopidine. Lancet 1998;352: 1036-7.
19. Tarantolo SR, Landmark JD, Iwen PC, Kessinger A, Chan WC, Hinrichs SH. Bartonella-like erythrocyte inclusions in thrombotic thrombocytopenic purpura (letter). Lancet 1997; 350:1602.
20. Creager AJ, Brecher ME, Bandarenko N. Thrombotic thrombocytopenic purpura that is refractory to therapeutic plasma exchange in two patients with occult infection. Transfusion 1998;38:419-23.
21. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colamino NM, Azocar J, Seder RH, Hong SL, Deykin D. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982;307:1432.
22. Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lämmle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 1997;89(9):3097-103.
23. Tsai H-M, Lian EC-Y. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585-94.
24. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998;339:1578-84.
25. Ruggenenti P, Galbusera M, Cornejo RP, Bellavita P, Remuzzi G. Thrombotic thrombocytopenic purpura: Evidence that infusion rather than removal of plasma induces remission of the disease. Am J Kidney Dis 1993;21(3):314-8.
26. Shepard KV, Bukowski RM. The treatment of thrombotic thrombocytopenic purpura with exchange transfusions, plasma infusions, and plasma exchange. Semin Hematol 1987;24(3):178-93.
27. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA, Canadian Apheresis Study Group. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991;325:393-7.
28. Rock G, Shumak KH, Sutton DMC, Buskard NA, Nair RC, Members of the Canadian Apheresis Study Group. Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Br J Haematol 1996;94: 383-6.
29. Byrnes JJ, Moake JL, Klug P, Periman P. Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. Am J Hematol 1990;34:169-74.
30. Klein HG, Dodd RY, Dzik WH, Luban NL, Ness PM, Pisciotto P, Schiff PD, Snyder EL. Current status of solvent/ detergent-treated plasma. Transfusion 1998;38:102-7.
31. Harrison CN, Lawrie AS, Iqbal A, Hunter A, Machin SJ. Plasma exchange with solvent/detergent-treated plasma of resistant thrombotic thrombocytopenic purpura. Br J Haematol 1996;94(4)S:756-8.
32. Guidelines for therapeutic hemapheresis: American Association of Blood Banks: 1992-3 AABB Extracorporeal therapy committee. Bethesda, MD, 1992.
33. Gilcher RO, Strauss RG, Ciavarella D, Kasprisin DO, Kiprov DD, Klein HG, Mcleod BC. Management of renal disorders. J Clin Apheresis 1993;8(4):258-169.
34. Breckenridge RL, Solberg LA, Pineda A, Petitt RM, Dharkar DD. Treatment of thrombotic thrombocytopenic purpura with plasma exchange, anti-platelet agents, corticosteroid, and plasma infusion: Mayo Clinic experience. J Clin Apheresis 1982;1:6-13.
35. Harkness DR, Byrnes JJ, Lian EC-Y. Hazard of platelet transfusion in thrombotic thrombocytopenic purpura. JAMA 1981;246:1931.
36. Gordon LI, Kwaan HC, Rossi EC. Deleterious effects of platelet transfusions and recovery thrombocytosis in patients with thrombotic microangiopathy. Semin Hematol 1987;24: 194.
37. Winslow GA, Nelson EW. Thrombotic thrombocytopenic purpura: Indications for and results of splenectomy. Am J Surg 1995;170:558-63.